Accuronix Therapeutics
Business Services · Missouri, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
4340 Duncan Ave Ste 210, St. Louis, Miss...Website
www.accuronix.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Accuronix Therapeutics
Accuronix develops innovative cancer therapies that selectively target cancer cells and deliver cytotoxic payloads, with the goal of improving efficacy while minimizing toxicity risks. Their lead candidate, ACXT-3102, is in preclinical development for treating pancreatic adenocarcinoma and other rare tumors, utilizing their unique drug-targeting technology. The company prioritizes partnerships to accelerate the development of their therapies, addressing significant unmet needs in oncology. With a focus on targeting the -2 receptor, Accuronix aims to advance new treatments for challenging cancer types.Explore more
Accuronix Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Accuronix Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Accuronix Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Accuronix Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Accuronix Therapeutics
Earning: See what the market has to say on Accuronix Therapeutics recently announced quarterly report
Product Launch: Get notified when Accuronix Therapeutics launches new products
Check if Accuronix Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Accuronix Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Accuronix Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Accuronix Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Accuronix Therapeutics
Compare insights from companies similar to Accuronix Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Accuronix Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Accuronix Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Accuronix Therapeutics.
Accuronix Therapeutics Tech Stack
A closer look at the technologies used by Accuronix Therapeutics
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Accuronix Therapeutics
Sign Up For FreeTo access detailed company insights
Accuronix develops innovative cancer therapies that selectively target cancer cells and deliver cytotoxic payloads, with the goal of improving efficacy while minimizing toxicity risks. Their lead candidate, ACXT-3102, is in preclinical development for treating pancreatic adenocarcinoma and other rare tumors, utilizing their unique drug-targeting te... Read More
